ClinicalTrials.gg
Drug

Abametapir clinical trials

studies test it
5
open now
0
in phase 3
2
first study started
2014

How each study uses abametapir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
24 Jul 2020 · XEGLYZE · NDA 206966 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Abametapir Lotion 0.74% w/w
5

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 3
2

Who runs them

Industry 5 · Other 0

Dr. Reddy's Laboratories Limited (5)

Studies

Open first, then newest update. How each study uses abametapir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Codes

What other systems call abametapir · ClinicalTrials.gg INT015327

  • UNII (FDA) 6UO390AMFBABAMETAPIRConfirmed FDA, Wikidata
  • RxNorm 2475532One source FDA
  • Wikidata Q27265547abametapirConfirmed FDA, Wikidata
  • NCI Thesaurus C166964AbametapirOne source FDA
  • DrugBank DB11932One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.